Proteinopathy: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{SI}} | |||
{{Infobox medical condition | |||
| name = Proteinopathy | |||
| image = [[File:Proteopathy_Abeta_deposits_in_Alzheimer_disease.jpg|250px]] | |||
| caption = [[Amyloid beta]] deposits in [[Alzheimer's disease]] | |||
| field = [[Neurology]], [[Pathology]] | |||
| symptoms = [[Neurodegeneration]], [[organ dysfunction]] | |||
| complications = [[Alzheimer's disease]], [[Parkinson's disease]], [[Amyloidosis]] | |||
| onset = Varies by condition | |||
| duration = Chronic | |||
| causes = Misfolded [[proteins]] | |||
| risks = [[Genetic predisposition]], [[aging]], [[environmental factors]] | |||
| diagnosis = [[Biopsy]], [[imaging studies]], [[genetic testing]] | |||
| differential = Other causes of [[neurodegeneration]] | |||
| treatment = Symptomatic, [[disease-modifying therapies]] under investigation | |||
| prognosis = Varies by specific condition | |||
| frequency = Common in [[elderly]] | |||
}} | |||
[[File:Amyloid_Liver_Congo_Red_Bar=100um.jpg|Amyloid deposits in liver stained with Congo Red|thumb|left]] | |||
[[File:Immunostaining_(brown)_of_alpha-synuclein_in_Lewy_Bodies_and_Lewy_Neurites_in_the_neocortex_of_a_patient_with_Lewy_Body_Disease.jpg|Alpha-synuclein in Lewy Bodies and Lewy Neurites|thumb]] | |||
[[File:Tauopathy_in_Alzheimer's_disease.jpg|Tauopathy in Alzheimer's disease|thumb|left]] | |||
'''Proteinopathy''' refers to a broad range of diseases that are caused by [[protein]]s that become structurally abnormal, and thereby disrupt the function of cells, tissues and organs of the body. Proteinopathies include [[Alzheimer's disease]], [[Parkinson's disease]], [[Huntington's disease]], [[Amyotrophic lateral sclerosis]], and [[Prion diseases]]. | '''Proteinopathy''' refers to a broad range of diseases that are caused by [[protein]]s that become structurally abnormal, and thereby disrupt the function of cells, tissues and organs of the body. Proteinopathies include [[Alzheimer's disease]], [[Parkinson's disease]], [[Huntington's disease]], [[Amyotrophic lateral sclerosis]], and [[Prion diseases]]. | ||
== Introduction == | |||
== | |||
Proteinopathies are caused by certain proteins that fail to fold into their normal configuration. In this misfolded state, the proteins can become toxic and can aggregate into insoluble [[protein aggregates]] that contribute to the disease process. This is a common mechanism in neurodegenerative diseases, systemic diseases, and many other conditions. | Proteinopathies are caused by certain proteins that fail to fold into their normal configuration. In this misfolded state, the proteins can become toxic and can aggregate into insoluble [[protein aggregates]] that contribute to the disease process. This is a common mechanism in neurodegenerative diseases, systemic diseases, and many other conditions. | ||
== Types of Proteinopathies == | == Types of Proteinopathies == | ||
There are several types of proteinopathies, which are classified based on the protein involved and the disease it causes. These include: | There are several types of proteinopathies, which are classified based on the protein involved and the disease it causes. These include: | ||
* [[Amyloidosis]]: This is a group of diseases in which abnormal proteins, known as amyloids, build up in tissues and organs. | * [[Amyloidosis]]: This is a group of diseases in which abnormal proteins, known as amyloids, build up in tissues and organs. | ||
* [[Tauopathies]]: These are a class of neurodegenerative diseases associated with the pathological aggregation of tau protein in the human brain. | * [[Tauopathies]]: These are a class of neurodegenerative diseases associated with the pathological aggregation of tau protein in the human brain. | ||
* [[Synucleinopathies]]: These are neurodegenerative diseases characterized by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibers or glial cells. | * [[Synucleinopathies]]: These are neurodegenerative diseases characterized by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibers or glial cells. | ||
== Treatment == | == Treatment == | ||
Treatment for proteinopathies is largely symptomatic, focusing on improving quality of life and slowing disease progression. However, research is ongoing to find treatments that can target the underlying protein misfolding and aggregation. | Treatment for proteinopathies is largely symptomatic, focusing on improving quality of life and slowing disease progression. However, research is ongoing to find treatments that can target the underlying protein misfolding and aggregation. | ||
== See Also == | == See Also == | ||
* [[Neurodegenerative disease]] | * [[Neurodegenerative disease]] | ||
* [[Protein folding]] | * [[Protein folding]] | ||
* [[Protein aggregation]] | * [[Protein aggregation]] | ||
== References == | == References == | ||
<references /> | <references /> | ||
{{stub}} | {{stub}} | ||
[[Category:Proteinopathies]] | [[Category:Proteinopathies]] | ||
[[Category:Neurodegenerative disorders]] | [[Category:Neurodegenerative disorders]] | ||
[[Category:Protein folding]] | [[Category:Protein folding]] | ||
Latest revision as of 04:51, 13 April 2025
Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's medical weight loss NYC, sleep center NYC
Philadelphia medical weight loss and Philadelphia sleep clinics
| Proteinopathy | |
|---|---|
| File:Proteopathy Abeta deposits in Alzheimer disease.jpg | |
| Synonyms | N/A |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Neurodegeneration, organ dysfunction |
| Complications | Alzheimer's disease, Parkinson's disease, Amyloidosis |
| Onset | Varies by condition |
| Duration | Chronic |
| Types | N/A |
| Causes | Misfolded proteins |
| Risks | Genetic predisposition, aging, environmental factors |
| Diagnosis | Biopsy, imaging studies, genetic testing |
| Differential diagnosis | Other causes of neurodegeneration |
| Prevention | N/A |
| Treatment | Symptomatic, disease-modifying therapies under investigation |
| Medication | N/A |
| Prognosis | Varies by specific condition |
| Frequency | Common in elderly |
| Deaths | N/A |
Proteinopathy refers to a broad range of diseases that are caused by proteins that become structurally abnormal, and thereby disrupt the function of cells, tissues and organs of the body. Proteinopathies include Alzheimer's disease, Parkinson's disease, Huntington's disease, Amyotrophic lateral sclerosis, and Prion diseases.
Introduction[edit]
Proteinopathies are caused by certain proteins that fail to fold into their normal configuration. In this misfolded state, the proteins can become toxic and can aggregate into insoluble protein aggregates that contribute to the disease process. This is a common mechanism in neurodegenerative diseases, systemic diseases, and many other conditions.
Types of Proteinopathies[edit]
There are several types of proteinopathies, which are classified based on the protein involved and the disease it causes. These include:
- Amyloidosis: This is a group of diseases in which abnormal proteins, known as amyloids, build up in tissues and organs.
- Tauopathies: These are a class of neurodegenerative diseases associated with the pathological aggregation of tau protein in the human brain.
- Synucleinopathies: These are neurodegenerative diseases characterized by the abnormal accumulation of aggregates of alpha-synuclein protein in neurons, nerve fibers or glial cells.
Treatment[edit]
Treatment for proteinopathies is largely symptomatic, focusing on improving quality of life and slowing disease progression. However, research is ongoing to find treatments that can target the underlying protein misfolding and aggregation.
See Also[edit]
References[edit]
<references />
_of_alpha-synuclein_in_Lewy_Bodies_and_Lewy_Neurites_in_the_neocortex_of_a_patient_with_Lewy_Body_Disease.jpg){kind=link}
